data_2ffk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ffk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 3' ' ' ALA . 58.7 mtt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.729 0.3 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -41.84 85.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.852 2.368 . . . . 0.0 112.403 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -87.58 10.55 17.53 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.424 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 5' ' ' LEU . 90.8 p -64.56 -22.56 67.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.768 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 4' ' ' SER . 11.3 tp 58.66 117.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.557 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -77.21 50.85 0.79 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.779 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 50.45 -130.24 2.11 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.301 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 m -165.78 -44.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.763 0.316 . . . . 0.0 110.836 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.2 t -69.58 -21.02 63.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.028 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.403 ' O ' ' OG ' ' A' ' 13' ' ' SER . 10.4 t -49.73 132.53 21.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.723 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 127' ' ' SER . 12.0 t -60.96 -19.76 61.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.588 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.3 t -87.35 -24.84 24.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 10' ' ' SER . 56.4 p -77.48 -52.5 8.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.078 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 15' ' ' CYS . 11.5 t -157.31 175.41 14.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.902 0.382 . . . . 0.0 110.772 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.473 ' SG ' ' CD2' ' A' ' 23' ' ' HIS . 4.9 t -71.87 150.79 43.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.573 -179.872 -157.633 115.964 102.822 104.099 2.02 104.196 -164.276 -63.198 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.1 p -69.43 168.62 14.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.763 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -116.29 7.64 14.05 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.466 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.487 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 0.4 OUTLIER -85.55 96.04 9.51 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.104 0.478 . . . . 0.0 110.279 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -33.34 -47.94 0.22 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.831 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -80.98 31.92 0.32 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -141.69 144.11 33.92 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.493 ' CD2' ' OD2' ' A' ' 201' ' ' ASP . 59.8 m80 -141.64 152.03 43.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.175 0.512 . . . . 0.0 110.816 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.483 ' O ' ' SD ' ' A' ' 202' ' ' MET . 20.3 m-70 -92.02 79.08 5.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.499 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.604 ' N ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -68.2 127.63 33.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.205 -178.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.565 ' N ' ' SD ' ' A' ' 202' ' ' MET . . . -133.63 -168.5 11.87 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.0 tt -149.07 151.89 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.929 0.395 . . . . 0.0 110.76 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.31 129.13 23.19 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.4 t -137.78 94.48 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.923 0.392 . . . . 0.0 110.047 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.85 150.53 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.506 ' O ' ' ND2' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -152.04 130.07 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.266 0.555 . . . . 0.0 111.328 -179.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -116.16 127.24 54.64 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.798 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -127.77 131.33 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.054 0.454 . . . . 0.0 110.407 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.8 m -101.08 131.38 47.02 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.843 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -78.51 153.68 31.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.796 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.494 ' C ' ' H ' ' A' ' 37' ' ' GLN . 8.5 tt0 -75.61 147.61 39.44 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.45 0.25 0.32 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.205 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 35' ' ' GLN . 79.1 mt-30 -98.35 -45.84 6.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.663 0.268 . . . . 0.0 111.251 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.9 p -46.77 146.44 2.62 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.899 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.495 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 88.3 Cg_endo -76.75 176.32 10.26 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.035 1.824 . . . . 0.0 111.388 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.65 142.94 56.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.202 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 39' ' ' PRO . 4.2 p30 -164.34 92.22 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.529 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 44' ' ' ILE . 10.7 t70 -99.67 -14.03 19.1 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.238 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -57.56 86.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.437 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 42' ' ' ASP . 2.5 tp -94.47 164.51 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.818 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.4 m 58.25 34.98 24.61 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.005 0.191 . . . . 0.0 110.817 -179.441 -69.602 -59.038 -43.202 106.725 2.026 106.608 -58.948 -48.71 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.409 ' O ' ' OG ' ' A' ' 47' ' ' SER . 77.9 mt-30 -54.03 -54.2 42.49 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.115 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 46' ' ' GLN . 17.4 m -166.02 167.41 16.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.092 0.472 . . . . 0.0 110.984 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.5 m -143.39 137.04 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.413 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.0 m -127.67 107.63 10.07 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.935 0.398 . . . . 0.0 110.968 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -87.73 134.56 33.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.257 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.3 mt -142.7 156.09 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.2 m -152.15 146.79 25.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 54' ' ' SER . 1.7 tm-20 -50.76 173.22 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.516 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 46.9 m -56.7 -20.53 22.25 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 56' ' ' SER . 29.3 tt0 55.66 165.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.584 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 55' ' ' GLU . 31.5 p 28.14 -107.67 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.325 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -176.68 59.19 0.17 Allowed Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.396 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.38 -47.1 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.633 2.222 . . . . 0.0 111.651 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -171.54 79.85 0.5 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.441 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -43.16 118.35 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.442 2.095 . . . . 0.0 112.176 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.98 78.37 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.779 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.6 t 63.24 72.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.548 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 52.71 69.6 0.67 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.274 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.0 t -114.36 -3.47 13.08 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.543 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -128.17 -138.27 0.24 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.284 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.403 ' O ' ' OD2' ' A' ' 67' ' ' ASP . 70.9 m-20 -73.92 -19.27 60.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.066 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.403 ' OD2' ' O ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER 73.75 -3.98 2.36 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.565 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.3 t -141.89 -137.43 0.11 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.332 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.412 ' C ' ' HG ' ' A' ' 70' ' ' SER . 68.6 p -58.87 147.43 33.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.775 0.321 . . . . 0.0 110.502 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 69' ' ' THR . 50.1 m -149.94 54.78 0.94 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.558 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.29 -95.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.866 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -156.78 14.39 0.28 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.423 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.07 -72.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.696 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.54 130.58 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.462 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -179.59 69.45 0.17 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.188 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -88.66 110.96 0.59 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.196 2.597 . . . . 0.0 112.377 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -86.42 171.45 7.49 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.345 2.03 . . . . 0.0 111.545 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.0 p -124.36 131.34 53.51 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.759 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 p -95.37 120.86 36.33 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -107.56 151.64 25.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.065 0.46 . . . . 0.0 110.711 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -138.92 152.83 48.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.152 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.3 m -140.35 66.66 1.38 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.92 0.391 . . . . 0.0 110.041 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.0 tt -71.65 109.4 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.564 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.1 mt -91.52 145.72 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.636 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.21 163.1 11.93 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.23 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.403 ' O ' ' OD1' ' A' ' 41' ' ' ASN . . . 60.69 22.84 60.12 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.137 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.03 6.05 55.24 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.5 tp -121.7 149.4 43.29 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.59 ' CZ ' HD22 ' A' ' 91' ' ' ASN . 69.7 ttt-85 -116.51 104.36 11.35 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.7 ttt -100.83 139.5 36.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.052 0.454 . . . . 0.0 110.139 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.59 HD22 ' CZ ' ' A' ' 89' ' ' ARG . 0.8 OUTLIER -143.73 144.26 31.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.171 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -147.02 146.31 29.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.988 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -116.86 96.64 0.72 Allowed Glycine 0 C--N 1.339 0.725 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.778 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -76.62 123.07 25.56 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 p -121.82 116.62 24.78 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.777 0.323 . . . . 0.0 110.736 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.64 ' HZ2' ' HE ' ' B' ' 18' ' ' ARG . 41.7 mtpt 61.1 35.5 18.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.722 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 70.1 m -122.44 149.47 55.3 Favored Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.304 -58.452 -89.993 112.113 104.334 2.021 104.599 46.07 173.009 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -36.1 157.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.342 2.028 . . . . 0.0 112.534 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -83.89 112.56 20.24 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.586 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.5 tt -66.94 128.67 30.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.242 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -123.53 -11.03 7.87 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 117' ' ' SER . 29.7 p -116.56 127.13 54.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.993 0.425 . . . . 0.0 111.161 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 35.7 mt -136.88 119.47 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 p -138.84 171.53 14.2 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.07 0.462 . . . . 0.0 110.795 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -165.17 168.88 16.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.213 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.8 p -168.11 163.98 13.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.413 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.12 135.47 43.21 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.715 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.11 107.68 3.81 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.035 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.81 -129.48 10.32 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.517 ' N ' HD21 ' A' ' 110' ' ' ASN . 0.0 OUTLIER -102.82 21.76 14.97 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.683 0.278 . . . . 0.0 110.554 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 t -133.25 160.18 38.04 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.011 0.434 . . . . 0.0 110.388 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.5 m -144.37 141.48 24.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.768 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 30' ' ' ILE . 24.5 t-20 -117.67 162.36 18.16 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.009 0.433 . . . . 0.0 110.898 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -145.35 127.12 15.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.163 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.451 ' CD ' ' HG ' ' A' ' 117' ' ' SER . 0.6 OUTLIER -106.49 108.42 19.92 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.219 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.5 ' C ' ' HG ' ' A' ' 117' ' ' SER . 1.8 mm? -113.33 115.03 27.5 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.5 ' HG ' ' C ' ' A' ' 116' ' ' LEU . 3.8 m -159.39 172.14 18.49 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.833 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.509 ' HG ' ' H ' ' A' ' 119' ' ' VAL . 35.8 t -91.71 166.79 12.6 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.59 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.509 ' H ' ' HG ' ' A' ' 118' ' ' SER . 35.9 m -96.69 140.82 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.029 0.443 . . . . 0.0 111.475 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.494 ' N ' ' OE1' ' A' ' 123' ' ' GLN . 13.5 m -81.15 152.4 71.05 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.73 146.25 86.3 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.789 1.659 . . . . 0.0 111.548 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.2 47.02 7.22 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.494 ' OE1' ' N ' ' A' ' 120' ' ' SER . 84.3 mt-30 -135.39 -7.11 2.25 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.832 0.349 . . . . 0.0 110.358 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.59 13.6 43.75 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.748 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -139.29 144.45 38.34 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.61 149.29 4.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.485 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 11' ' ' SER . 36.4 t -157.28 59.87 1.89 Allowed Pre-proline 0 N--CA 1.462 0.174 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.709 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -36.85 162.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.143 2.562 . . . . 0.0 113.192 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -141.94 147.35 36.87 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.117 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.505 ' CD1' ' N ' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -134.8 -179.9 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.823 0.344 . . . . 0.0 110.68 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.8 t -85.67 163.13 18.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.293 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.502 ' CD2' ' N ' ' A' ' 132' ' ' HIS . 4.0 m170 -51.06 -40.43 58.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.048 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -53.64 -57.26 11.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.823 0.344 . . . . 0.0 110.959 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -66.07 -29.6 69.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.752 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.13 -57.92 7.33 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.343 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 56.2 mt -57.35 -32.06 66.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.138 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.98 -40.83 78.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.68 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 38.3 mtt -69.93 -57.77 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.784 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 51.4 mt -46.96 -22.23 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.659 -178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -83.95 -48.72 9.68 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 141' ' ' ASP . 0.5 OUTLIER -80.2 -28.57 38.62 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.511 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.5 t -47.73 120.23 3.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.943 0.401 . . . . 0.0 111.24 -179.148 173.009 46.07 112.113 104.599 2.021 104.334 -89.993 -58.452 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -140.95 127.01 19.44 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.032 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.8 m -116.44 128.71 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.939 0.4 . . . . 0.0 110.704 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.9 p -101.33 164.28 11.86 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.764 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.8 mt -145.9 146.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.81 0.338 . . . . 0.0 110.488 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -157.97 87.4 0.93 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.309 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.97 152.09 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.181 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -145.92 170.74 15.99 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.538 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.7 t -91.34 117.38 29.61 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.598 0.237 . . . . 0.0 110.646 -179.766 -160.398 125.93 -68.493 103.955 2.021 103.893 173.522 -67.85 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.0 p -93.05 -174.73 3.65 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 110.346 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -159.39 -2.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.111 0.481 . . . . 0.0 109.975 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' A' ' 153' ' ' GLU . 2.5 mp0 -62.2 103.46 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.717 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -79.2 10.17 3.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.964 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -49.15 163.35 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 110.668 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -75.33 172.59 12.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.672 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 65.3 p -92.61 137.72 32.12 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -113.88 91.35 3.61 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.796 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.9 pt -120.23 175.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.479 ' C ' ' H ' ' A' ' 162' ' ' HIS . 4.5 tppt? -133.92 132.95 40.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.71 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 38.8 p -63.78 3.37 0.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.461 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.479 ' H ' ' C ' ' A' ' 160' ' ' LYS . 46.9 t-80 -79.0 117.36 66.4 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.315 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -40.11 157.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.796 1.664 . . . . 0.0 112.227 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.8 p -83.12 132.63 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.596 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' A' ' 165' ' ' LEU . 7.5 mp -82.0 117.73 22.43 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.974 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.31 168.86 35.48 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 116.386 -0.37 . . . . 0.0 112.46 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.516 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.9 t -98.32 7.94 45.52 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.04 0.448 . . . . 0.0 110.001 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.489 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 1.3 m-20 58.95 -1.85 0.11 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.782 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.516 ' H ' ' C ' ' A' ' 167' ' ' SER . 8.8 tp -93.41 144.74 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.425 ' O ' ' NH2' ' A' ' 198' ' ' ARG . 13.1 m -106.46 146.06 31.01 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.775 0.321 . . . . 0.0 110.295 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -82.06 40.99 0.65 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.176 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 205' ' ' GLU . 53.2 pttt -67.65 -175.34 0.52 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.045 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -92.28 126.02 37.19 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.572 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.593 ' CG2' ' H ' ' A' ' 175' ' ' SER . 14.1 p -155.3 179.65 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.099 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.593 ' H ' ' CG2' ' A' ' 174' ' ' VAL . 14.8 t -32.41 137.9 0.06 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.027 0.441 . . . . 0.0 112.02 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.432 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 43.5 p90 -94.42 128.56 41.04 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.232 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -140.76 115.87 9.86 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.363 -0.38 . . . . 0.0 109.993 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -62.24 97.93 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.181 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 29.7 mt -108.22 -35.7 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.476 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 36.2 mt -65.59 119.29 9.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.011 0.434 . . . . 0.0 110.566 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.77 -125.33 1.35 Allowed Glycine 0 C--N 1.332 0.348 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.468 ' HG ' ' N ' ' A' ' 183' ' ' THR . 26.7 t -76.0 150.8 37.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.708 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.484 ' O ' ' CD1' ' B' ' 13' ' ' PHE . 32.7 p -143.39 95.94 2.83 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.716 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 7.1 mm -95.21 127.54 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.143 0.497 . . . . 0.0 110.472 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 10.5 m -132.63 124.09 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.602 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -90.94 103.37 16.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.217 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -45.36 -32.82 2.22 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.069 -178.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.412 ' O ' ' SG ' ' A' ' 189' ' ' CYS . 82.0 tttt -36.88 -26.79 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.462 ' N ' ' O ' ' A' ' 187' ' ' THR . 86.9 m -151.34 27.88 0.66 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.979 -67.85 173.522 -68.493 103.893 2.021 103.955 125.93 -160.398 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.6 m -151.84 104.57 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.198 0.523 . . . . 0.0 110.657 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -79.32 -56.45 4.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.026 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 16.6 t-20 -111.33 169.05 9.05 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.484 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.501 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 0.7 OUTLIER -173.43 106.26 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -100.18 134.0 43.75 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.239 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -116.99 131.02 57.06 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.394 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.85 125.43 14.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 43.0 t -133.46 160.69 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.523 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.425 ' NH2' ' O ' ' A' ' 170' ' ' SER . 47.8 ttt180 -158.94 154.68 26.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.365 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.8 mt -149.93 123.92 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.749 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.424 ' O ' ' SD ' ' A' ' 202' ' ' MET . . . -173.69 -159.1 19.56 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.579 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.493 ' OD2' ' CD2' ' A' ' 22' ' ' HIS . 1.6 m-20 -79.43 141.29 36.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.833 0.349 . . . . 0.0 110.594 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.593 ' N ' ' SD ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -97.67 0.16 46.65 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.83 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 73.9 m -105.8 -47.7 3.82 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.98 179.407 -63.198 -164.276 102.822 104.196 2.02 104.099 115.964 -157.633 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -164.83 124.72 1.91 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.035 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 172' ' ' LYS . 13.3 pt-20 -42.6 156.47 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.346 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 208' ' ' GLU . 14.9 t -142.41 22.24 2.02 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 46.7 p 51.13 -78.8 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 206' ' ' SER . 33.8 mt-10 -52.12 -40.21 60.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.697 0.284 . . . . 0.0 111.4 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.31 -7.14 58.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.914 0.388 . . . . 0.0 110.189 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -97.08 137.38 36.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.96 0.41 . . . . 0.0 111.117 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.98 -179.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.605 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.478 ' HZ1' ' CB ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -171.11 163.82 7.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.336 0.588 . . . . 0.0 111.336 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 213' ' ' ASP . 2.6 p-10 -162.31 171.93 16.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.238 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.445 ' C ' ' CD1' ' A' ' 215' ' ' PHE . . . 159.09 169.04 21.96 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.557 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 214' ' ' GLY . 67.4 m-85 -145.05 178.33 8.12 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -135.09 104.59 5.99 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.065 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -100.17 115.99 31.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.177 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.06 118.99 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.241 0.543 . . . . 0.0 110.441 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 38.7 t70 50.98 43.88 28.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.385 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.24 0.74 78.65 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.807 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.9 t -98.81 116.98 32.26 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.849 0.357 . . . . 0.0 110.719 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.31 159.0 15.23 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.966 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.8 t -171.23 121.13 0.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.346 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -77.87 138.42 38.91 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.76 113.38 0.46 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.606 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -77.49 104.4 8.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 81.5 p -129.78 163.79 25.47 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.347 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.33 95.45 0.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.439 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -88.82 29.52 1.02 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.508 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 31.0 m -72.22 -37.32 69.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.836 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.8 t -99.91 0.75 41.87 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.053 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.8 tp -38.11 -33.18 0.08 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.462 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.6 pp -157.19 156.38 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.358 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -75.74 104.87 6.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.213 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 94.0 p -64.86 -12.62 50.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.083 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 238' ' ' LEU . 25.4 m -77.05 -52.48 9.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.673 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -62.39 6.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 236' ' ' THR . 96.5 mt -70.04 148.84 48.34 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.502 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -141.42 125.87 17.7 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.27 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.49 126.64 28.01 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.416 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 23.7 m -92.67 -2.92 55.68 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.105 179.979 -48.71 -58.948 -43.202 106.608 2.026 106.725 -59.038 -69.602 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.618 -179.689 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.724 0.297 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.27 114.64 4.04 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.634 2.223 . . . . 0.0 111.738 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.82 153.38 8.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.495 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.8 176.99 1.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.15 -0.548 . . . . 0.0 111.927 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.443 ' HG ' ' N ' ' B' ' 6' ' ' ASP . 13.6 t -71.6 -88.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.792 0.329 . . . . 0.0 110.552 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . 0.443 ' N ' ' HG ' ' B' ' 5' ' ' SER . 7.6 m-20 -150.86 59.29 3.34 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.421 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' B' ' 8' ' ' PRO . 82.0 Cg_endo -75.34 114.66 4.04 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.546 2.164 . . . . 0.0 111.368 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' B' ' 7' ' ' PRO . 88.4 Cg_exo -45.05 176.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 121.759 1.64 . . . . 0.0 111.441 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 39.4 p -144.29 -173.81 4.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.294 0.568 . . . . 0.0 111.697 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.49 117.25 22.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.217 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.525 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 89.3 m -135.83 117.53 15.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.274 179.819 -68.129 -176.779 69.563 104.149 2.02 104.277 141.801 -52.813 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 69.4 m -34.77 132.29 0.33 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.08 -179.933 -71.653 -131.98 103.02 103.612 2.016 104.077 123.085 -163.358 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.525 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 10.0 m-85 -115.17 -28.79 6.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.995 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -157.66 155.29 29.77 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.235 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -112.59 158.58 19.79 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.963 0.411 . . . . 0.0 111.618 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -82.0 141.72 33.0 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.82 -35.91 32.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.393 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.64 ' HE ' ' HZ2' ' A' ' 96' ' ' LYS . 1.5 tpt85 -87.86 127.04 35.34 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.868 0.366 . . . . 0.0 111.949 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -80.91 127.66 32.8 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' B' ' 20' ' ' LEU . 9.2 mp -90.77 111.91 50.49 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 116.843 -0.162 . . . . 0.0 110.727 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -42.74 152.63 0.18 Allowed 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.03 1.82 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' B' ' 25' ' ' VAL . 13.6 ptm180 -45.61 -45.02 13.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.383 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -39.5 -32.98 0.14 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -107.65 41.09 1.58 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.73 0.3 . . . . 0.0 110.544 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' B' ' 22' ' ' ARG . 47.5 t -150.64 90.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.161 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 33.3 m -91.66 -23.69 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 28.4 t0 -155.96 -179.95 8.63 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.898 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.514 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 9.7 p90 -161.24 170.65 19.84 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 111.68 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.449 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 62.7 t80 -157.34 156.28 32.07 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.558 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.449 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 66.1 mt-10 -103.91 150.28 24.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.928 0.394 . . . . 0.0 110.889 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' THR . . . . . 0.412 ' O ' ' O ' ' B' ' 30' ' ' GLU . 79.5 p -55.08 -113.28 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.99 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -150.19 -141.73 0.11 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.694 0.283 . . . . 0.0 110.581 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.489 ' C ' ' H ' ' B' ' 35' ' ' CYS . 61.3 m -145.16 -26.18 0.48 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.279 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.3 mm? -54.73 -9.49 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.832 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.489 ' H ' ' C ' ' B' ' 33' ' ' SER . 44.9 m -119.6 119.46 33.82 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.488 179.474 -52.813 141.801 69.563 104.277 2.02 104.149 -176.779 -68.129 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 41.4 t -72.53 36.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.466 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' B' ' 35' ' ' CYS . 77.9 mm-40 -154.13 56.99 1.67 Allowed Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.72 -167.63 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.776 2.317 . . . . 0.0 113.209 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 171.66 176.48 0.08 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.816 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.1 t -106.84 134.44 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.032 0.444 . . . . 0.0 110.195 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 t -111.84 133.91 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.775 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -115.2 144.69 43.31 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.143 0.497 . . . . 0.0 111.16 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.439 ' NE2' ' OD2' ' B' ' 27' ' ' ASP . 74.5 mt-30 -93.42 170.63 9.46 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 4.7 p -139.76 -142.31 0.15 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.161 0.505 . . . . 0.0 111.07 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.468 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -127.23 -37.98 2.01 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.614 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.27 46.1 2.44 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.946 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 15.6 m -151.43 -83.22 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.439 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 155.75 -87.38 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -148.05 146.95 29.07 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.882 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 41.8 t -152.31 125.3 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.081 0.467 . . . . 0.0 109.93 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.24 161.72 8.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.451 -179.672 -163.358 123.085 103.02 104.077 2.016 103.612 -131.98 -71.653 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.9 132.64 12.28 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.402 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 53' ' ' ASP . 25.9 p-10 -67.79 124.04 88.45 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.84 0.01 9.34 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.259 1.306 . . . . 0.0 111.023 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 33.6 t -72.02 -13.49 61.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.249 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -100.1 127.19 46.38 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.145 0.498 . . . . 0.0 110.399 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 20.3 m -49.26 -48.75 45.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.403 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 49.4 p-90 -56.11 -28.3 57.27 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.633 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.1 t -71.76 -35.78 56.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.981 0.419 . . . . 0.0 110.024 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -72.82 -45.82 56.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.452 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -59.5 -35.17 73.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.973 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.0 m-85 -65.11 -40.43 94.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.575 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.51 -46.4 80.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.806 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -57.17 -34.3 68.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.081 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -71.17 -40.38 71.3 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.966 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -72.26 -20.19 61.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.517 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -71.28 -34.8 71.0 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.22 -101.72 0.07 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 . . . . . 0 C--O 1.219 -0.534 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.609 179.904 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 3' ' ' ALA . 58.7 mtt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.729 0.3 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -41.84 85.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.852 2.368 . . . . 0.0 112.403 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -87.58 10.55 17.53 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.424 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 5' ' ' LEU . 90.8 p -64.56 -22.56 67.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.768 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 4' ' ' SER . 11.3 tp 58.66 117.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.557 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -77.21 50.85 0.79 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.779 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 50.45 -130.24 2.11 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.301 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 m -165.78 -44.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.763 0.316 . . . . 0.0 110.836 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.2 t -69.58 -21.02 63.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.028 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 t -49.73 132.53 21.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.723 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 127' ' ' SER . 12.0 t -60.96 -19.76 61.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.588 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.3 t -87.35 -24.84 24.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 p -77.48 -52.5 8.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.078 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 15' ' ' CYS . 11.5 t -157.31 175.41 14.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.902 0.382 . . . . 0.0 110.772 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.473 ' SG ' ' CD2' ' A' ' 23' ' ' HIS . 4.9 t -71.87 150.79 43.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.573 -179.872 -157.633 115.964 102.822 104.099 2.02 104.196 -164.276 -63.198 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.1 p -69.43 168.62 14.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.763 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -116.29 7.64 14.05 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.466 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.487 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 0.4 OUTLIER -85.55 96.04 9.51 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.104 0.478 . . . . 0.0 110.279 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -33.34 -47.94 0.22 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.831 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -80.98 31.92 0.32 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -141.69 144.11 33.92 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -141.64 152.03 43.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.175 0.512 . . . . 0.0 110.816 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.483 ' O ' ' SD ' ' A' ' 202' ' ' MET . 20.3 m-70 -92.02 79.08 5.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.499 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.604 ' N ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -68.2 127.63 33.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.205 -178.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.565 ' N ' ' SD ' ' A' ' 202' ' ' MET . . . -133.63 -168.5 11.87 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.0 tt -149.07 151.89 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.929 0.395 . . . . 0.0 110.76 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.31 129.13 23.19 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.71 HG22 HG13 ' A' ' 197' ' ' VAL . 76.4 t -137.78 94.48 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.923 0.392 . . . . 0.0 110.047 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.85 150.53 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.04 130.07 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.266 0.555 . . . . 0.0 111.328 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -116.16 127.24 54.64 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.798 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -127.77 131.33 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.054 0.454 . . . . 0.0 110.407 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.8 m -101.08 131.38 47.02 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.843 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -78.51 153.68 31.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.796 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' A' ' 37' ' ' GLN . 8.5 tt0 -75.61 147.61 39.44 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.45 0.25 0.32 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.205 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.454 ' H ' ' C ' ' A' ' 35' ' ' GLN . 29.6 mt-30 -98.35 -45.84 6.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.663 0.268 . . . . 0.0 111.251 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.9 p -46.77 146.44 2.62 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.899 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.495 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 88.3 Cg_endo -76.75 176.32 10.26 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.035 1.824 . . . . 0.0 111.388 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 40' ' ' THR . 0.3 OUTLIER -67.65 142.94 56.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.202 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 39' ' ' PRO . 4.2 p30 -164.34 92.22 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.529 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 44' ' ' ILE . 10.7 t70 -99.67 -14.03 19.1 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.238 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -57.56 86.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.437 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 42' ' ' ASP . 2.5 tp -94.47 164.51 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.818 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.4 m 58.25 34.98 24.61 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.005 0.191 . . . . 0.0 110.817 -179.441 -69.602 -59.038 -43.202 106.725 2.026 106.608 -58.948 -48.71 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.404 ' OE1' HG22 ' A' ' 84' ' ' ILE . 77.9 mt-30 -54.03 -54.2 42.49 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.115 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.4 m -166.02 167.41 16.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.092 0.472 . . . . 0.0 110.984 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.5 m -143.39 137.04 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.413 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.0 m -127.67 107.63 10.07 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.935 0.398 . . . . 0.0 110.968 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -87.73 134.56 33.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.257 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.3 mt -142.7 156.09 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.2 m -152.15 146.79 25.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 54' ' ' SER . 1.7 tm-20 -50.76 173.22 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.503 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 46.9 m -56.7 -20.53 22.25 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 56' ' ' SER . 29.3 tt0 55.66 165.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.584 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 55' ' ' GLU . 31.5 p 28.14 -107.67 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.325 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -176.68 59.19 0.17 Allowed Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.396 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.38 -47.1 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.633 2.222 . . . . 0.0 111.651 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -171.54 79.85 0.5 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.441 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -43.16 118.35 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.442 2.095 . . . . 0.0 112.176 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.98 78.37 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.779 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.6 t 63.24 72.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.548 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 52.71 69.6 0.67 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.274 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.0 t -114.36 -3.47 13.08 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.543 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -128.17 -138.27 0.24 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.284 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.403 ' O ' ' OD2' ' A' ' 67' ' ' ASP . 70.9 m-20 -73.92 -19.27 60.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.066 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.403 ' OD2' ' O ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER 73.75 -3.98 2.36 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.565 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.3 t -141.89 -137.43 0.11 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.332 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.6 p -58.87 147.43 33.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.775 0.321 . . . . 0.0 110.502 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.1 m -149.94 54.78 0.94 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.558 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.479 HG23 ' H ' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -55.29 -95.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.866 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.479 ' H ' HG23 ' A' ' 71' ' ' VAL . 17.2 pt-20 -156.78 14.39 0.28 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.423 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.07 -72.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.696 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.54 130.58 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.462 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -179.59 69.45 0.17 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.188 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -88.66 110.96 0.59 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.196 2.597 . . . . 0.0 112.377 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -86.42 171.45 7.49 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.345 2.03 . . . . 0.0 111.545 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.0 p -124.36 131.34 53.51 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.759 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 p -95.37 120.86 36.33 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -107.56 151.64 25.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.065 0.46 . . . . 0.0 110.711 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -138.92 152.83 48.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.152 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.3 m -140.35 66.66 1.38 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.92 0.391 . . . . 0.0 110.041 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.514 ' O ' HG23 ' A' ' 83' ' ' ILE . 15.0 tt -71.65 109.4 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.564 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.404 HG22 ' OE1' ' A' ' 46' ' ' GLN . 18.1 mt -91.52 145.72 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.636 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.21 163.1 11.93 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.23 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.403 ' O ' ' OD1' ' A' ' 41' ' ' ASN . . . 60.69 22.84 60.12 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.137 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.03 6.05 55.24 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.5 tp -121.7 149.4 43.29 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.619 ' CZ ' HD21 ' A' ' 91' ' ' ASN . 69.7 ttt-85 -116.51 104.36 11.35 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.7 ttt -100.83 139.5 36.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.052 0.454 . . . . 0.0 110.139 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.619 HD21 ' CZ ' ' A' ' 89' ' ' ARG . 0.8 OUTLIER -143.73 144.26 31.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.171 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -147.02 146.31 29.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.988 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -116.86 96.64 0.72 Allowed Glycine 0 C--N 1.339 0.725 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.778 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -76.62 123.07 25.56 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 p -121.82 116.62 24.78 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.777 0.323 . . . . 0.0 110.736 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.579 ' HZ2' ' CZ ' ' B' ' 18' ' ' ARG . 41.7 mtpt 61.1 35.5 18.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.722 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 70.1 m -122.44 149.47 55.3 Favored Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.304 -58.452 -89.993 112.113 104.334 2.021 104.599 46.07 173.009 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -36.1 157.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.342 2.028 . . . . 0.0 112.534 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -83.89 112.56 20.24 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.586 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.463 ' O ' HG23 ' A' ' 100' ' ' ILE . 6.5 tt -66.94 128.67 30.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.242 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -123.53 -11.03 7.87 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.7 p -116.56 127.13 54.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.993 0.425 . . . . 0.0 111.161 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 35.7 mt -136.88 119.47 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 p -138.84 171.53 14.2 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.07 0.462 . . . . 0.0 110.795 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -165.17 168.88 16.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.213 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.8 p -168.11 163.98 13.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.413 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.12 135.47 43.21 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.715 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.11 107.68 3.81 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.035 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.81 -129.48 10.32 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -102.82 21.76 14.97 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.683 0.278 . . . . 0.0 110.554 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 t -133.25 160.18 38.04 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.011 0.434 . . . . 0.0 110.388 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.5 m -144.37 141.48 24.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.768 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -117.67 162.36 18.16 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.009 0.433 . . . . 0.0 110.898 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -145.35 127.12 15.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.163 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.436 ' C ' ' NE ' ' A' ' 115' ' ' ARG . 0.6 OUTLIER -106.49 108.42 19.92 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.219 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 116' ' ' LEU . 1.8 mm? -113.33 115.03 27.5 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.45 ' HG ' ' C ' ' A' ' 116' ' ' LEU . 3.8 m -159.39 172.14 18.49 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.833 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 t -91.71 166.79 12.6 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.59 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.9 m -96.69 140.82 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.029 0.443 . . . . 0.0 111.475 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.494 ' N ' ' OE1' ' A' ' 123' ' ' GLN . 13.5 m -81.15 152.4 71.05 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.73 146.25 86.3 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.789 1.659 . . . . 0.0 111.548 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.2 47.02 7.22 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.494 ' OE1' ' N ' ' A' ' 120' ' ' SER . 84.3 mt-30 -135.39 -7.11 2.25 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.832 0.349 . . . . 0.0 110.358 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.59 13.6 43.75 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.748 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -139.29 144.45 38.34 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.61 149.29 4.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.485 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 11' ' ' SER . 36.4 t -157.28 59.87 1.89 Allowed Pre-proline 0 N--CA 1.462 0.174 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.709 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -36.85 162.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.143 2.562 . . . . 0.0 113.192 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -141.94 147.35 36.87 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.117 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.725 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -134.8 -179.9 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.823 0.344 . . . . 0.0 110.68 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.8 t -85.67 163.13 18.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.293 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -51.06 -40.43 58.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.048 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -53.64 -57.26 11.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.823 0.344 . . . . 0.0 110.959 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -66.07 -29.6 69.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.752 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.13 -57.92 7.33 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.343 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 56.2 mt -57.35 -32.06 66.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.138 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.98 -40.83 78.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.68 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 38.3 mtt -69.93 -57.77 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.784 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 51.4 mt -46.96 -22.23 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.659 -178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -83.95 -48.72 9.68 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 141' ' ' ASP . 0.5 OUTLIER -80.2 -28.57 38.62 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.511 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.5 t -47.73 120.23 3.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.943 0.401 . . . . 0.0 111.24 -179.148 173.009 46.07 112.113 104.599 2.021 104.334 -89.993 -58.452 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -140.95 127.01 19.44 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.032 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 144' ' ' VAL . 17.8 m -116.44 128.71 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.939 0.4 . . . . 0.0 110.704 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.9 p -101.33 164.28 11.86 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.764 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.8 mt -145.9 146.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.81 0.338 . . . . 0.0 110.488 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -157.97 87.4 0.93 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.309 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.416 HD13 ' N ' ' A' ' 148' ' ' ILE . 0.0 OUTLIER -82.97 152.09 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.181 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -145.92 170.74 15.99 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.538 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.7 t -91.34 117.38 29.61 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.598 0.237 . . . . 0.0 110.646 -179.766 -160.398 125.93 -68.493 103.955 2.021 103.893 173.522 -67.85 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.0 p -93.05 -174.73 3.65 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 110.346 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.421 ' H ' ' H ' ' A' ' 153' ' ' GLU . 30.5 tt0 -159.39 -2.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.111 0.481 . . . . 0.0 109.975 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 153' ' ' GLU . 2.5 mp0 -62.2 103.46 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.717 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -79.2 10.17 3.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.964 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -49.15 163.35 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 110.668 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -75.33 172.59 12.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.672 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 65.3 p -92.61 137.72 32.12 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -113.88 91.35 3.61 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.796 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.9 pt -120.23 175.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 162' ' ' HIS . 4.5 tppt? -133.92 132.95 40.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.71 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 38.8 p -63.78 3.37 0.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.461 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.453 ' H ' ' C ' ' A' ' 160' ' ' LYS . 46.9 t-80 -79.0 117.36 66.4 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.315 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -40.11 157.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.796 1.664 . . . . 0.0 112.227 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.8 p -83.12 132.63 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.596 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 165' ' ' LEU . 7.5 mp -82.0 117.73 22.43 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.974 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.31 168.86 35.48 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 116.386 -0.37 . . . . 0.0 112.46 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.471 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.9 t -98.32 7.94 45.52 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.04 0.448 . . . . 0.0 110.001 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.489 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 1.3 m-20 58.95 -1.85 0.11 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.782 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.471 ' H ' ' C ' ' A' ' 167' ' ' SER . 8.8 tp -93.41 144.74 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.425 ' O ' ' NH2' ' A' ' 198' ' ' ARG . 13.1 m -106.46 146.06 31.01 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.775 0.321 . . . . 0.0 110.295 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -82.06 40.99 0.65 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.176 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -67.65 -175.34 0.52 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.045 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -92.28 126.02 37.19 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.572 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.763 HG22 ' H ' ' A' ' 175' ' ' SER . 14.1 p -155.3 179.65 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.099 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.763 ' H ' HG22 ' A' ' 174' ' ' VAL . 14.8 t -32.41 137.9 0.06 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.027 0.441 . . . . 0.0 112.02 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.432 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 43.5 p90 -94.42 128.56 41.04 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.232 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -140.76 115.87 9.86 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.363 -0.38 . . . . 0.0 109.993 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -62.24 97.93 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.181 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 29.7 mt -108.22 -35.7 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.476 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 36.2 mt -65.59 119.29 9.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.011 0.434 . . . . 0.0 110.566 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.77 -125.33 1.35 Allowed Glycine 0 C--N 1.332 0.348 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.7 t -76.0 150.8 37.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.708 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.484 ' O ' ' CD1' ' B' ' 13' ' ' PHE . 32.7 p -143.39 95.94 2.83 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.716 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 7.1 mm -95.21 127.54 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.143 0.497 . . . . 0.0 110.472 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 185' ' ' VAL . 10.5 m -132.63 124.09 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.602 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 190' ' ' VAL . 46.3 t0 -90.94 103.37 16.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.217 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -45.36 -32.82 2.22 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.069 -178.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.412 ' O ' ' SG ' ' A' ' 189' ' ' CYS . 82.0 tttt -36.88 -26.79 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.462 ' N ' ' O ' ' A' ' 187' ' ' THR . 86.9 m -151.34 27.88 0.66 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.979 -67.85 173.522 -68.493 103.893 2.021 103.955 125.93 -160.398 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 190' ' ' VAL . 35.6 m -151.84 104.57 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.198 0.523 . . . . 0.0 110.657 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -79.32 -56.45 4.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.026 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 16.6 t-20 -111.33 169.05 9.05 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.484 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.501 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 0.7 OUTLIER -173.43 106.26 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -100.18 134.0 43.75 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.239 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -116.99 131.02 57.06 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.394 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.85 125.43 14.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.71 HG13 HG22 ' A' ' 28' ' ' VAL . 43.0 t -133.46 160.69 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.523 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.527 ' N ' HG12 ' A' ' 197' ' ' VAL . 47.8 ttt180 -158.94 154.68 26.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.365 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.8 mt -149.93 123.92 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.749 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.424 ' O ' ' SD ' ' A' ' 202' ' ' MET . . . -173.69 -159.1 19.56 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.579 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.43 141.29 36.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.833 0.349 . . . . 0.0 110.594 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.593 ' N ' ' SD ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -97.67 0.16 46.65 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.83 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 73.9 m -105.8 -47.7 3.82 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.98 179.407 -63.198 -164.276 102.822 104.196 2.02 104.099 115.964 -157.633 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -164.83 124.72 1.91 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.035 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -42.6 156.47 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.346 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 208' ' ' GLU . 14.9 t -142.41 22.24 2.02 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 46.7 p 51.13 -78.8 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 206' ' ' SER . 33.8 mt-10 -52.12 -40.21 60.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.697 0.284 . . . . 0.0 111.4 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.31 -7.14 58.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.914 0.388 . . . . 0.0 110.189 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -97.08 137.38 36.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.96 0.41 . . . . 0.0 111.117 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.98 -179.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.605 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.11 163.82 7.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.336 0.588 . . . . 0.0 111.336 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 213' ' ' ASP . 2.6 p-10 -162.31 171.93 16.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.238 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.445 ' C ' ' CD1' ' A' ' 215' ' ' PHE . . . 159.09 169.04 21.96 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.557 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 214' ' ' GLY . 67.4 m-85 -145.05 178.33 8.12 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -135.09 104.59 5.99 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.065 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -100.17 115.99 31.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.177 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 218' ' ' VAL . 7.8 p -140.06 118.99 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.241 0.543 . . . . 0.0 110.441 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 38.7 t70 50.98 43.88 28.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.385 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.24 0.74 78.65 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.807 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.9 t -98.81 116.98 32.26 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.849 0.357 . . . . 0.0 110.719 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.31 159.0 15.23 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.966 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.8 t -171.23 121.13 0.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.346 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -77.87 138.42 38.91 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.76 113.38 0.46 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.606 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -77.49 104.4 8.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 81.5 p -129.78 163.79 25.47 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.347 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.33 95.45 0.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.439 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -88.82 29.52 1.02 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.508 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 31.0 m -72.22 -37.32 69.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.836 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.8 t -99.91 0.75 41.87 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.053 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 233' ' ' ILE . 10.8 tp -38.11 -33.18 0.08 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.462 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 232' ' ' LEU . 2.6 pp -157.19 156.38 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.358 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -75.74 104.87 6.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.213 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 94.0 p -64.86 -12.62 50.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.083 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 238' ' ' LEU . 25.4 m -77.05 -52.48 9.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.673 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -62.39 6.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' A' ' 236' ' ' THR . 96.5 mt -70.04 148.84 48.34 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.502 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -141.42 125.87 17.7 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.27 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.49 126.64 28.01 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.416 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 23.7 m -92.67 -2.92 55.68 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.105 179.979 -48.71 -58.948 -43.202 106.608 2.026 106.725 -59.038 -69.602 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.618 -179.689 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.724 0.297 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.27 114.64 4.04 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.634 2.223 . . . . 0.0 111.738 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.82 153.38 8.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.495 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.8 176.99 1.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.15 -0.548 . . . . 0.0 111.927 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.6 t -71.6 -88.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.792 0.329 . . . . 0.0 110.552 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -150.86 59.29 3.34 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.421 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' B' ' 8' ' ' PRO . 82.0 Cg_endo -75.34 114.66 4.04 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.546 2.164 . . . . 0.0 111.368 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' B' ' 7' ' ' PRO . 88.4 Cg_exo -45.05 176.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 121.759 1.64 . . . . 0.0 111.441 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 39.4 p -144.29 -173.81 4.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.294 0.568 . . . . 0.0 111.697 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.49 117.25 22.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.217 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.525 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 89.3 m -135.83 117.53 15.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.274 179.819 -68.129 -176.779 69.563 104.149 2.02 104.277 141.801 -52.813 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 69.4 m -34.77 132.29 0.33 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.08 -179.933 -71.653 -131.98 103.02 103.612 2.016 104.077 123.085 -163.358 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.525 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 10.0 m-85 -115.17 -28.79 6.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.995 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -157.66 155.29 29.77 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.235 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -112.59 158.58 19.79 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.963 0.411 . . . . 0.0 111.618 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.401 HG22 ' H ' ' B' ' 16' ' ' THR . 2.8 t -82.0 141.72 33.0 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.82 -35.91 32.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.393 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.579 ' CZ ' ' HZ2' ' A' ' 96' ' ' LYS . 1.5 tpt85 -87.86 127.04 35.34 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.868 0.366 . . . . 0.0 111.949 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -80.91 127.66 32.8 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.489 HD12 ' N ' ' B' ' 20' ' ' LEU . 9.2 mp -90.77 111.91 50.49 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 116.843 -0.162 . . . . 0.0 110.727 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -42.74 152.63 0.18 Allowed 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.03 1.82 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' B' ' 25' ' ' VAL . 13.6 ptm180 -45.61 -45.02 13.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.383 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -39.5 -32.98 0.14 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -107.65 41.09 1.58 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.73 0.3 . . . . 0.0 110.544 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' B' ' 22' ' ' ARG . 47.5 t -150.64 90.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.161 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 33.3 m -91.66 -23.69 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 28.4 t0 -155.96 -179.95 8.63 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.898 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.483 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 9.7 p90 -161.24 170.65 19.84 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 111.68 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.449 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 62.7 t80 -157.34 156.28 32.07 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.558 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.449 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 66.1 mt-10 -103.91 150.28 24.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.928 0.394 . . . . 0.0 110.889 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' THR . . . . . 0.412 ' O ' ' O ' ' B' ' 30' ' ' GLU . 79.5 p -55.08 -113.28 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.99 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -150.19 -141.73 0.11 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.694 0.283 . . . . 0.0 110.581 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.451 ' C ' ' H ' ' B' ' 35' ' ' CYS . 61.3 m -145.16 -26.18 0.48 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.279 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.3 mm? -54.73 -9.49 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.832 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.451 ' H ' ' C ' ' B' ' 33' ' ' SER . 44.9 m -119.6 119.46 33.82 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.488 179.474 -52.813 141.801 69.563 104.277 2.02 104.149 -176.779 -68.129 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 41.4 t -72.53 36.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.466 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.447 ' H ' ' C ' ' B' ' 35' ' ' CYS . 77.9 mm-40 -154.13 56.99 1.67 Allowed Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 58.2 Cg_endo -67.72 -167.63 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.776 2.317 . . . . 0.0 113.209 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 171.66 176.48 0.08 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.816 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.1 t -106.84 134.44 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.032 0.444 . . . . 0.0 110.195 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 t -111.84 133.91 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.775 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -115.2 144.69 43.31 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.143 0.497 . . . . 0.0 111.16 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.439 ' NE2' ' OD2' ' B' ' 27' ' ' ASP . 74.5 mt-30 -93.42 170.63 9.46 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 4.7 p -139.76 -142.31 0.15 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.161 0.505 . . . . 0.0 111.07 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.468 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -127.23 -37.98 2.01 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.614 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.27 46.1 2.44 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.946 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.621 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 15.6 m -151.43 -83.22 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.439 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.75 -87.38 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -148.05 146.95 29.07 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.882 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 41.8 t -152.31 125.3 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.081 0.467 . . . . 0.0 109.93 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.24 161.72 8.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.451 -179.672 -163.358 123.085 103.02 104.077 2.016 103.612 -131.98 -71.653 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.9 132.64 12.28 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.402 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 53' ' ' ASP . 25.9 p-10 -67.79 124.04 88.45 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.84 0.01 9.34 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.259 1.306 . . . . 0.0 111.023 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 33.6 t -72.02 -13.49 61.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.249 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -100.1 127.19 46.38 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.145 0.498 . . . . 0.0 110.399 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 20.3 m -49.26 -48.75 45.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.403 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 49.4 p-90 -56.11 -28.3 57.27 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.633 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.1 t -71.76 -35.78 56.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.981 0.419 . . . . 0.0 110.024 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -72.82 -45.82 56.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.452 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -59.5 -35.17 73.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.973 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.0 m-85 -65.11 -40.43 94.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.575 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.51 -46.4 80.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.806 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -57.17 -34.3 68.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.081 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -71.17 -40.38 71.3 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.966 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -72.26 -20.19 61.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.517 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -71.28 -34.8 71.0 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.22 -101.72 0.07 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 . . . . . 0 C--O 1.219 -0.534 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.609 179.904 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 3' ' ' ALA . 58.7 mtt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.729 0.3 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -41.84 85.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.852 2.368 . . . . 0.0 112.403 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -87.58 10.55 17.53 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.424 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.404 ' O ' ' O ' ' A' ' 5' ' ' LEU . 90.8 p -64.56 -22.56 67.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.768 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 4' ' ' SER . 11.3 tp 58.66 117.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.557 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -77.21 50.85 0.79 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.779 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 50.45 -130.24 2.11 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.301 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 m -165.78 -44.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.763 0.316 . . . . 0.0 110.836 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.2 t -69.58 -21.02 63.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.028 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 t -49.73 132.53 21.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.723 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 127' ' ' SER . 12.0 t -60.96 -19.76 61.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.588 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.3 t -87.35 -24.84 24.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 p -77.48 -52.5 8.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.078 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 15' ' ' CYS . 11.5 t -157.31 175.41 14.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.902 0.382 . . . . 0.0 110.772 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.473 ' SG ' ' CD2' ' A' ' 23' ' ' HIS . 4.9 t -71.87 150.79 43.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.573 -179.872 -157.633 115.964 102.822 104.099 2.02 104.196 -164.276 -63.198 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.1 p -69.43 168.62 14.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.763 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -116.29 7.64 14.05 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.466 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.487 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 0.4 OUTLIER -85.55 96.04 9.51 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.104 0.478 . . . . 0.0 110.279 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -33.34 -47.94 0.22 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.831 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -80.98 31.92 0.32 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -141.69 144.11 33.92 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.493 ' CD2' ' OD2' ' A' ' 201' ' ' ASP . 59.8 m80 -141.64 152.03 43.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.175 0.512 . . . . 0.0 110.816 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.483 ' O ' ' SD ' ' A' ' 202' ' ' MET . 20.3 m-70 -92.02 79.08 5.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.499 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.604 ' N ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -68.2 127.63 33.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.205 -178.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.565 ' N ' ' SD ' ' A' ' 202' ' ' MET . . . -133.63 -168.5 11.87 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.0 tt -149.07 151.89 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.929 0.395 . . . . 0.0 110.76 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.31 129.13 23.19 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.71 HG22 HG13 ' A' ' 197' ' ' VAL . 76.4 t -137.78 94.48 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.923 0.392 . . . . 0.0 110.047 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.85 150.53 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.506 ' O ' ' ND2' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -152.04 130.07 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.266 0.555 . . . . 0.0 111.328 -179.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -116.16 127.24 54.64 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.798 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -127.77 131.33 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.054 0.454 . . . . 0.0 110.407 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.8 m -101.08 131.38 47.02 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.843 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -78.51 153.68 31.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.796 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' A' ' 37' ' ' GLN . 8.5 tt0 -75.61 147.61 39.44 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.45 0.25 0.32 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.205 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.454 ' H ' ' C ' ' A' ' 35' ' ' GLN . 79.1 mt-30 -98.35 -45.84 6.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.663 0.268 . . . . 0.0 111.251 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.9 p -46.77 146.44 2.62 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.899 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.495 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 88.3 Cg_endo -76.75 176.32 10.26 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.035 1.824 . . . . 0.0 111.388 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 40' ' ' THR . 0.3 OUTLIER -67.65 142.94 56.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.202 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 39' ' ' PRO . 4.2 p30 -164.34 92.22 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.529 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 44' ' ' ILE . 10.7 t70 -99.67 -14.03 19.1 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.238 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -57.56 86.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.437 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 42' ' ' ASP . 2.5 tp -94.47 164.51 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.818 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.4 m 58.25 34.98 24.61 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.005 0.191 . . . . 0.0 110.817 -179.441 -69.602 -59.038 -43.202 106.725 2.026 106.608 -58.948 -48.71 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.404 ' OE1' HG22 ' A' ' 84' ' ' ILE . 77.9 mt-30 -54.03 -54.2 42.49 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.115 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.4 m -166.02 167.41 16.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.092 0.472 . . . . 0.0 110.984 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.5 m -143.39 137.04 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.413 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.0 m -127.67 107.63 10.07 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.935 0.398 . . . . 0.0 110.968 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -87.73 134.56 33.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.257 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.3 mt -142.7 156.09 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.2 m -152.15 146.79 25.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 54' ' ' SER . 1.7 tm-20 -50.76 173.22 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.503 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 46.9 m -56.7 -20.53 22.25 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 56' ' ' SER . 29.3 tt0 55.66 165.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.584 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 55' ' ' GLU . 31.5 p 28.14 -107.67 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.325 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -176.68 59.19 0.17 Allowed Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.396 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.38 -47.1 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.633 2.222 . . . . 0.0 111.651 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -171.54 79.85 0.5 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.441 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -43.16 118.35 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.442 2.095 . . . . 0.0 112.176 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.98 78.37 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.779 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.6 t 63.24 72.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.548 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 52.71 69.6 0.67 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.274 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.0 t -114.36 -3.47 13.08 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.543 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -128.17 -138.27 0.24 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.284 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.403 ' O ' ' OD2' ' A' ' 67' ' ' ASP . 70.9 m-20 -73.92 -19.27 60.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.066 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.403 ' OD2' ' O ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER 73.75 -3.98 2.36 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.565 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.3 t -141.89 -137.43 0.11 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.332 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.6 p -58.87 147.43 33.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.775 0.321 . . . . 0.0 110.502 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.1 m -149.94 54.78 0.94 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.558 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.479 HG23 ' H ' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -55.29 -95.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.866 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.479 ' H ' HG23 ' A' ' 71' ' ' VAL . 17.2 pt-20 -156.78 14.39 0.28 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.423 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.07 -72.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.696 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.54 130.58 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.462 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -179.59 69.45 0.17 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.188 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -88.66 110.96 0.59 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.196 2.597 . . . . 0.0 112.377 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -86.42 171.45 7.49 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.345 2.03 . . . . 0.0 111.545 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.0 p -124.36 131.34 53.51 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.759 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 p -95.37 120.86 36.33 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -107.56 151.64 25.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.065 0.46 . . . . 0.0 110.711 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -138.92 152.83 48.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.152 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.3 m -140.35 66.66 1.38 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.92 0.391 . . . . 0.0 110.041 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.514 ' O ' HG23 ' A' ' 83' ' ' ILE . 15.0 tt -71.65 109.4 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.564 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.404 HG22 ' OE1' ' A' ' 46' ' ' GLN . 18.1 mt -91.52 145.72 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.636 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.21 163.1 11.93 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.23 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.403 ' O ' ' OD1' ' A' ' 41' ' ' ASN . . . 60.69 22.84 60.12 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.137 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.03 6.05 55.24 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.5 tp -121.7 149.4 43.29 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.619 ' CZ ' HD21 ' A' ' 91' ' ' ASN . 69.7 ttt-85 -116.51 104.36 11.35 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.7 ttt -100.83 139.5 36.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.052 0.454 . . . . 0.0 110.139 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.619 HD21 ' CZ ' ' A' ' 89' ' ' ARG . 0.8 OUTLIER -143.73 144.26 31.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.171 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -147.02 146.31 29.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.988 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -116.86 96.64 0.72 Allowed Glycine 0 C--N 1.339 0.725 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.778 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -76.62 123.07 25.56 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 p -121.82 116.62 24.78 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.777 0.323 . . . . 0.0 110.736 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.579 ' HZ2' ' CZ ' ' B' ' 18' ' ' ARG . 41.7 mtpt 61.1 35.5 18.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.722 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 70.1 m -122.44 149.47 55.3 Favored Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.304 -58.452 -89.993 112.113 104.334 2.021 104.599 46.07 173.009 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -36.1 157.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.342 2.028 . . . . 0.0 112.534 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -83.89 112.56 20.24 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.586 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.463 ' O ' HG23 ' A' ' 100' ' ' ILE . 6.5 tt -66.94 128.67 30.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.242 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -123.53 -11.03 7.87 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.7 p -116.56 127.13 54.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.993 0.425 . . . . 0.0 111.161 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 35.7 mt -136.88 119.47 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 p -138.84 171.53 14.2 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.07 0.462 . . . . 0.0 110.795 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -165.17 168.88 16.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.213 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.8 p -168.11 163.98 13.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.413 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.12 135.47 43.21 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.715 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.11 107.68 3.81 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.035 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.81 -129.48 10.32 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.6 ' H ' ' ND2' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -102.82 21.76 14.97 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.683 0.278 . . . . 0.0 110.554 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 t -133.25 160.18 38.04 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.011 0.434 . . . . 0.0 110.388 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.5 m -144.37 141.48 24.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.768 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 30' ' ' ILE . 24.5 t-20 -117.67 162.36 18.16 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.009 0.433 . . . . 0.0 110.898 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -145.35 127.12 15.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.163 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.436 ' C ' ' NE ' ' A' ' 115' ' ' ARG . 0.6 OUTLIER -106.49 108.42 19.92 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.219 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 116' ' ' LEU . 1.8 mm? -113.33 115.03 27.5 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.45 ' HG ' ' C ' ' A' ' 116' ' ' LEU . 3.8 m -159.39 172.14 18.49 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.833 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 t -91.71 166.79 12.6 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.59 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.9 m -96.69 140.82 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.029 0.443 . . . . 0.0 111.475 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.494 ' N ' ' OE1' ' A' ' 123' ' ' GLN . 13.5 m -81.15 152.4 71.05 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.73 146.25 86.3 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.789 1.659 . . . . 0.0 111.548 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.2 47.02 7.22 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.494 ' OE1' ' N ' ' A' ' 120' ' ' SER . 84.3 mt-30 -135.39 -7.11 2.25 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.832 0.349 . . . . 0.0 110.358 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.59 13.6 43.75 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.748 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -139.29 144.45 38.34 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.61 149.29 4.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.485 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 11' ' ' SER . 36.4 t -157.28 59.87 1.89 Allowed Pre-proline 0 N--CA 1.462 0.174 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.709 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -36.85 162.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.143 2.562 . . . . 0.0 113.192 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -141.94 147.35 36.87 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.117 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.725 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -134.8 -179.9 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.823 0.344 . . . . 0.0 110.68 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.8 t -85.67 163.13 18.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.293 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.502 ' CD2' ' N ' ' A' ' 132' ' ' HIS . 4.0 m170 -51.06 -40.43 58.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.048 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -53.64 -57.26 11.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.823 0.344 . . . . 0.0 110.959 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -66.07 -29.6 69.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.752 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.13 -57.92 7.33 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.343 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 56.2 mt -57.35 -32.06 66.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.138 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.98 -40.83 78.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.68 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 38.3 mtt -69.93 -57.77 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.784 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 51.4 mt -46.96 -22.23 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.659 -178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -83.95 -48.72 9.68 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 141' ' ' ASP . 0.5 OUTLIER -80.2 -28.57 38.62 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.511 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 31.5 t -47.73 120.23 3.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.943 0.401 . . . . 0.0 111.24 -179.148 173.009 46.07 112.113 104.599 2.021 104.334 -89.993 -58.452 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -140.95 127.01 19.44 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.032 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 144' ' ' VAL . 17.8 m -116.44 128.71 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.939 0.4 . . . . 0.0 110.704 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.9 p -101.33 164.28 11.86 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.764 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.8 mt -145.9 146.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.81 0.338 . . . . 0.0 110.488 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -157.97 87.4 0.93 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.309 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.416 HD13 ' N ' ' A' ' 148' ' ' ILE . 0.0 OUTLIER -82.97 152.09 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.181 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -145.92 170.74 15.99 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.538 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.7 t -91.34 117.38 29.61 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.598 0.237 . . . . 0.0 110.646 -179.766 -160.398 125.93 -68.493 103.955 2.021 103.893 173.522 -67.85 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.0 p -93.05 -174.73 3.65 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 110.346 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.421 ' H ' ' H ' ' A' ' 153' ' ' GLU . 30.5 tt0 -159.39 -2.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.111 0.481 . . . . 0.0 109.975 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 153' ' ' GLU . 2.5 mp0 -62.2 103.46 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.717 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -79.2 10.17 3.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.964 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -49.15 163.35 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 110.668 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -75.33 172.59 12.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.672 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 65.3 p -92.61 137.72 32.12 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -113.88 91.35 3.61 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.796 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.9 pt -120.23 175.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 162' ' ' HIS . 4.5 tppt? -133.92 132.95 40.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.71 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 38.8 p -63.78 3.37 0.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.461 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.453 ' H ' ' C ' ' A' ' 160' ' ' LYS . 46.9 t-80 -79.0 117.36 66.4 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.315 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -40.11 157.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.796 1.664 . . . . 0.0 112.227 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.8 p -83.12 132.63 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.596 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 165' ' ' LEU . 7.5 mp -82.0 117.73 22.43 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.974 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.31 168.86 35.48 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 116.386 -0.37 . . . . 0.0 112.46 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.471 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.9 t -98.32 7.94 45.52 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.04 0.448 . . . . 0.0 110.001 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.489 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 1.3 m-20 58.95 -1.85 0.11 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.782 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.471 ' H ' ' C ' ' A' ' 167' ' ' SER . 8.8 tp -93.41 144.74 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.425 ' O ' ' NH2' ' A' ' 198' ' ' ARG . 13.1 m -106.46 146.06 31.01 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.775 0.321 . . . . 0.0 110.295 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -82.06 40.99 0.65 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.176 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -67.65 -175.34 0.52 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.045 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -92.28 126.02 37.19 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.572 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.763 HG22 ' H ' ' A' ' 175' ' ' SER . 14.1 p -155.3 179.65 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.099 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.763 ' H ' HG22 ' A' ' 174' ' ' VAL . 14.8 t -32.41 137.9 0.06 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.027 0.441 . . . . 0.0 112.02 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.432 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 43.5 p90 -94.42 128.56 41.04 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.232 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -140.76 115.87 9.86 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.363 -0.38 . . . . 0.0 109.993 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -62.24 97.93 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.181 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 29.7 mt -108.22 -35.7 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.476 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 36.2 mt -65.59 119.29 9.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.011 0.434 . . . . 0.0 110.566 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.77 -125.33 1.35 Allowed Glycine 0 C--N 1.332 0.348 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.7 t -76.0 150.8 37.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.708 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.484 ' O ' ' CD1' ' B' ' 13' ' ' PHE . 32.7 p -143.39 95.94 2.83 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.716 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 7.1 mm -95.21 127.54 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.143 0.497 . . . . 0.0 110.472 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 185' ' ' VAL . 10.5 m -132.63 124.09 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.602 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 190' ' ' VAL . 46.3 t0 -90.94 103.37 16.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.217 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -45.36 -32.82 2.22 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.069 -178.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.412 ' O ' ' SG ' ' A' ' 189' ' ' CYS . 82.0 tttt -36.88 -26.79 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.462 ' N ' ' O ' ' A' ' 187' ' ' THR . 86.9 m -151.34 27.88 0.66 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.979 -67.85 173.522 -68.493 103.893 2.021 103.955 125.93 -160.398 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 190' ' ' VAL . 35.6 m -151.84 104.57 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.198 0.523 . . . . 0.0 110.657 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -79.32 -56.45 4.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.026 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 16.6 t-20 -111.33 169.05 9.05 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.484 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.501 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 0.7 OUTLIER -173.43 106.26 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -100.18 134.0 43.75 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.239 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -116.99 131.02 57.06 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.394 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.85 125.43 14.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.71 HG13 HG22 ' A' ' 28' ' ' VAL . 43.0 t -133.46 160.69 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.523 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.527 ' N ' HG12 ' A' ' 197' ' ' VAL . 47.8 ttt180 -158.94 154.68 26.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.365 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.8 mt -149.93 123.92 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.749 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.424 ' O ' ' SD ' ' A' ' 202' ' ' MET . . . -173.69 -159.1 19.56 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.579 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.493 ' OD2' ' CD2' ' A' ' 22' ' ' HIS . 1.6 m-20 -79.43 141.29 36.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.833 0.349 . . . . 0.0 110.594 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.593 ' N ' ' SD ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -97.67 0.16 46.65 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.83 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 73.9 m -105.8 -47.7 3.82 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.98 179.407 -63.198 -164.276 102.822 104.196 2.02 104.099 115.964 -157.633 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -164.83 124.72 1.91 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.035 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -42.6 156.47 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.346 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 208' ' ' GLU . 14.9 t -142.41 22.24 2.02 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 46.7 p 51.13 -78.8 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 206' ' ' SER . 33.8 mt-10 -52.12 -40.21 60.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.697 0.284 . . . . 0.0 111.4 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.31 -7.14 58.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.914 0.388 . . . . 0.0 110.189 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -97.08 137.38 36.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.96 0.41 . . . . 0.0 111.117 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.98 -179.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.605 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.11 163.82 7.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.336 0.588 . . . . 0.0 111.336 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 213' ' ' ASP . 2.6 p-10 -162.31 171.93 16.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.238 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.445 ' C ' ' CD1' ' A' ' 215' ' ' PHE . . . 159.09 169.04 21.96 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.557 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 214' ' ' GLY . 67.4 m-85 -145.05 178.33 8.12 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -135.09 104.59 5.99 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.065 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -100.17 115.99 31.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.177 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 218' ' ' VAL . 7.8 p -140.06 118.99 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.241 0.543 . . . . 0.0 110.441 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 38.7 t70 50.98 43.88 28.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.385 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.24 0.74 78.65 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.807 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.9 t -98.81 116.98 32.26 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.849 0.357 . . . . 0.0 110.719 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.31 159.0 15.23 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.966 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.8 t -171.23 121.13 0.52 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.346 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -77.87 138.42 38.91 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.76 113.38 0.46 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.606 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -77.49 104.4 8.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 81.5 p -129.78 163.79 25.47 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.347 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.33 95.45 0.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.439 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -88.82 29.52 1.02 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.508 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 31.0 m -72.22 -37.32 69.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.836 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 23.8 t -99.91 0.75 41.87 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.053 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 233' ' ' ILE . 10.8 tp -38.11 -33.18 0.08 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.462 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 232' ' ' LEU . 2.6 pp -157.19 156.38 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.358 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -75.74 104.87 6.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.213 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 94.0 p -64.86 -12.62 50.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.083 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 238' ' ' LEU . 25.4 m -77.05 -52.48 9.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.673 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -62.39 6.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.444 ' H ' ' C ' ' A' ' 236' ' ' THR . 96.5 mt -70.04 148.84 48.34 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.502 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -141.42 125.87 17.7 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.27 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.49 126.64 28.01 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.416 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 23.7 m -92.67 -2.92 55.68 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.105 179.979 -48.71 -58.948 -43.202 106.608 2.026 106.725 -59.038 -69.602 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.618 -179.689 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.724 0.297 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.27 114.64 4.04 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.634 2.223 . . . . 0.0 111.738 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.82 153.38 8.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.495 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.8 176.99 1.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.15 -0.548 . . . . 0.0 111.927 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.6 t -71.6 -88.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.792 0.329 . . . . 0.0 110.552 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -150.86 59.29 3.34 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.421 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' B' ' 8' ' ' PRO . 82.0 Cg_endo -75.34 114.66 4.04 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.546 2.164 . . . . 0.0 111.368 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' B' ' 7' ' ' PRO . 88.4 Cg_exo -45.05 176.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 121.759 1.64 . . . . 0.0 111.441 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 39.4 p -144.29 -173.81 4.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.294 0.568 . . . . 0.0 111.697 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.49 117.25 22.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.217 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.525 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 89.3 m -135.83 117.53 15.01 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.274 179.819 -68.129 -176.779 69.563 104.149 2.02 104.277 141.801 -52.813 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 69.4 m -34.77 132.29 0.33 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.08 -179.933 -71.653 -131.98 103.02 103.612 2.016 104.077 123.085 -163.358 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.525 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 10.0 m-85 -115.17 -28.79 6.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.995 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -157.66 155.29 29.77 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.235 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -112.59 158.58 19.79 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.963 0.411 . . . . 0.0 111.618 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.401 HG22 ' H ' ' B' ' 16' ' ' THR . 2.8 t -82.0 141.72 33.0 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.82 -35.91 32.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.393 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.579 ' CZ ' ' HZ2' ' A' ' 96' ' ' LYS . 1.5 tpt85 -87.86 127.04 35.34 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.868 0.366 . . . . 0.0 111.949 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -80.91 127.66 32.8 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.489 HD12 ' N ' ' B' ' 20' ' ' LEU . 9.2 mp -90.77 111.91 50.49 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 116.843 -0.162 . . . . 0.0 110.727 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -42.74 152.63 0.18 Allowed 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.03 1.82 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' B' ' 25' ' ' VAL . 13.6 ptm180 -45.61 -45.02 13.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.383 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -39.5 -32.98 0.14 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -107.65 41.09 1.58 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.73 0.3 . . . . 0.0 110.544 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' B' ' 22' ' ' ARG . 47.5 t -150.64 90.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.161 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 33.3 m -91.66 -23.69 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 28.4 t0 -155.96 -179.95 8.63 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.898 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.483 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 9.7 p90 -161.24 170.65 19.84 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.104 0.478 . . . . 0.0 111.68 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.449 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 62.7 t80 -157.34 156.28 32.07 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.558 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.449 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 66.1 mt-10 -103.91 150.28 24.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.928 0.394 . . . . 0.0 110.889 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . 0.412 ' O ' ' O ' ' B' ' 30' ' ' GLU . 79.5 p -55.08 -113.28 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.99 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -150.19 -141.73 0.11 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.694 0.283 . . . . 0.0 110.581 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.451 ' C ' ' H ' ' B' ' 35' ' ' CYS . 61.3 m -145.16 -26.18 0.48 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.279 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.3 mm? -54.73 -9.49 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.832 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.451 ' H ' ' C ' ' B' ' 33' ' ' SER . 44.9 m -119.6 119.46 33.82 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.488 179.474 -52.813 141.801 69.563 104.277 2.02 104.149 -176.779 -68.129 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 41.4 t -72.53 36.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.466 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.447 ' H ' ' C ' ' B' ' 35' ' ' CYS . 77.9 mm-40 -154.13 56.99 1.67 Allowed Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 58.2 Cg_endo -67.72 -167.63 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.776 2.317 . . . . 0.0 113.209 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 171.66 176.48 0.08 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.816 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.1 t -106.84 134.44 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.032 0.444 . . . . 0.0 110.195 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 t -111.84 133.91 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.775 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -115.2 144.69 43.31 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.143 0.497 . . . . 0.0 111.16 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.439 ' NE2' ' OD2' ' B' ' 27' ' ' ASP . 74.5 mt-30 -93.42 170.63 9.46 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 4.7 p -139.76 -142.31 0.15 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.161 0.505 . . . . 0.0 111.07 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.468 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -127.23 -37.98 2.01 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.614 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.27 46.1 2.44 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.946 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.621 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 15.6 m -151.43 -83.22 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.439 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.75 -87.38 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -148.05 146.95 29.07 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.882 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 41.8 t -152.31 125.3 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.081 0.467 . . . . 0.0 109.93 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.24 161.72 8.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.451 -179.672 -163.358 123.085 103.02 104.077 2.016 103.612 -131.98 -71.653 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.9 132.64 12.28 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.402 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 53' ' ' ASP . 25.9 p-10 -67.79 124.04 88.45 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.84 0.01 9.34 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.259 1.306 . . . . 0.0 111.023 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 33.6 t -72.02 -13.49 61.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.249 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -100.1 127.19 46.38 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.145 0.498 . . . . 0.0 110.399 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 20.3 m -49.26 -48.75 45.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.403 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 49.4 p-90 -56.11 -28.3 57.27 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.633 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.1 t -71.76 -35.78 56.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.981 0.419 . . . . 0.0 110.024 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -72.82 -45.82 56.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.452 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -59.5 -35.17 73.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.973 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.0 m-85 -65.11 -40.43 94.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.575 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.51 -46.4 80.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.806 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -57.17 -34.3 68.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.081 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -71.17 -40.38 71.3 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.966 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -72.26 -20.19 61.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.517 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -71.28 -34.8 71.0 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.22 -101.72 0.07 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 . . . . . 0 C--O 1.219 -0.534 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.609 179.904 . . . . . . . . 0 0 . 1 stop_ save_